Kaplan–Meier analysis shows survival differences in non-small cell lung cancer patients, suggesting ICI can enhance outcomes when combined with chemotherapy.
Treatment outcomes according to history of ATB therapy. The Kaplan–Meier curves provide estimates of OS (A) and PFS (B) of the patients with a history of ATB therapy stratified by treatment with ICI plus chemotherapy and chemotherapy (n = 74). OS (C) and PFS (D) of the patients without a history of ATB therapy stratified by treatment with ICI plus chemotherapy and chemotherapy (n = 472). Chemo, chemotherapy; ICI–Chemo, ICI plus chemotherapy.
No takes yet. Share an insight, caveat, or question.
Hata et al. (2025) studied this question.